COMMUNIQUÉS West-GlobeNewswire

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes
13/11/2025
- Combined transactions will strengthen balance sheet and reduce outstanding debt by more than 90% - - $6 million PIPE financing with potential for over $7 million of additional capital via cash-exercise warrants - - [...]
Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates
13/11/2025
Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an Off-the-Shelf CD19-targeted CAR T-cell Product Candidate that Utilizes Less [...]
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
13/11/2025
Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response activity tracking within expected range HOUSTON, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Moleculin [...]
Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger
13/11/2025
Strategic transaction supports the advancement of Decoy’s rapid computational design and manufacturing of innovative peptide conjugate therapeutics through its IMP 3 ACT™ platform Combined company has pro forma cash of [...]
Clearmind Medicine Receives Final Approval to Expand its FDA Regulated Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
13/11/2025
Vancouver, Canada, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
Anathapindika Highlights Detoxification Supplements on Stress Awareness Day
13/11/2025
Holidays Come With Health-Related Stress, Making Detoxifying Nutraceuticals More Important Than Ever. Stress Awareness Day Is a Great Mental Step to Prepare for the Weeks Ahead. Fort Lauderdale, FL, Nov. 13, 2025 (GLOBE [...]
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
13/11/2025
NEW YORK and AMSTERDAM, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Atai Beckley N.V. (NASDAQ: ATAI) (“AtaiBeckley” or “Company”), a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by [...]
Four SPR® Abstracts Honored with Awards at 24th Annual ASRA Pain Meeting
13/11/2025
CLEVELAND, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SPR will have a significant presence at the upcoming annual ASRA Pain Medicine Meeting in Austin, Texas. A total of eight abstracts featuring the SPR SPRINT ® PNS System will [...]
LiveWorld Reports Third Quarter 2025 Financial Results
13/11/2025
LiveWorld continues to increase its AI investment CAMPBELL, Calif. and NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), today announced financial results for third quarter 2025. Q3 2025 [...]
HealthEquity to Enhance Member Experience with Agentic AI
13/11/2025
Nation's Largest HSA Custodian Leverages Parloa’s Advanced AI Technology to Deliver Personalized, Conversational Support for Millions of Members DRAPER, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- HealthEquity , Inc. ( [...]
Windtree Therapeutics Announces It Will Receive $7.5 Million In Cash and Securities from the Recently Executed Termination Agreement with an Environmental Services Company
13/11/2025
Windtree and TESI signed a letter of intent for a combination of cash and securities of TESI to be paid to Windtree The companies were engaged in a potential environmental services deal for Windtree to acquire Titan [...]
Parents Say Teens are Checked Out and Need Mental Health Support, According to New Report
13/11/2025
National survey spotlights fears of tech overuse NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- A new report from BODA Therapy finds that more than 78% of parents say their teens would or might benefit from mental-health [...]
Nexalin Technology Appoints Carmi Masha Technologies Ltd. as Exclusive Distributor in Israel
13/11/2025
Appointment Follows Israeli Ministry of Health Approval for Nexalin’s Gen-2 SYNC Device HOUSTON, TX, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in [...]
Inventiva annonce les modalités définitives ainsi que l'extension de l'offre au public d'American Depositary Shares d'approximativement 150 millions de dollars
13/11/2025
Daix (France), New York City (New York, États-Unis), le 13 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
13/11/2025
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]
U.S. Oral Surgery Management Secures New Partner Practices in Three States
13/11/2025
IRVING, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) -- U.S. Oral Surgery Management ( USOSM ) – a management services organization that exclusively serves premier oral and maxillofacial surgeons – has three new partner [...]
Zone School of Healing Celebrates Eight-Year Milestone as One of the Fastest-Growing Chiropractic & Healing Schools Worldwide
13/11/2025
FRANKLIN, Tenn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Zone School of Healing is proudly celebrating over eight years of transformative growth and success, solidifying its position as one of the fastest-growing schools [...]
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
13/11/2025
Daix (France), New York City (New York, États-Unis), le 13 novembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de [...]
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
13/11/2025
Daix (France), New York City (New York, United States), November 13, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (" Inventiva " or the " Company "), a clinical-stage biopharmaceutical company focused on the [...]

Pages